This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. ABSTRACT The major goals of the RCMI NPR are to establish Neurodegeneration Research Program (NRP), to enhance the infrastructure in this area of research at Florida A&M University and to increase research productivity of its faculty. The potential impact of establishing a Neurodegeneration research program cannot be overstated. Neurodegenerative diseases have a major impact on the health of the general public in and the elderly population in particular. Moreover, this program will have a major impact toward increasing the number of minority neuroscientists in the Nation. FAMU College of Pharmacy and Pharmaceutical Sciences is the leading institution, nationwide, in training African Americans with PhD's in pharmaceutical sciences and in the area of neuroscience. Therefore, the purpose of this application is to develop Neurodegeneration research by adding onto the human infrastructure and research resources that already exist. The long-term objectives are to establish an innovative and multidisciplinary program focusing on Neurodegeneration.
The specific aims are to: 1) support a Neurodegeneration research pilot project of a junior FAMU investigator. The project is expected to generate data that will be published, help establish the investigator and allow opportunities for faculty to seek and obtain independent research funds;2) support the development of research facilities to increase innovation of Neurodegeneration diseases research. Research facilities will include: a) Molecular Neurobiology, b) Cellular Imaging, and c) Neurochemistry/Receptors binding;3) offer in-house support to start Neurodegeneration research projects;and 4) enhance the research capabilities of Neurodegeneration investigators that will put them in a position to compete for mainstream funding through the establishment of internal and external mentoring program and provide training and academic interaction in the form of mini-sabbatical, seminars and workshops.
|Poku, Rosemary A; Salako, Olufisayo O; Amissah, Felix et al. (2017) Polyisoprenylated cysteinyl amide inhibitors induce caspase 3/7- and 8-mediated apoptosis and inhibit migration and invasion of metastatic prostate cancer cells. Am J Cancer Res 7:1515-1527|
|Ntantie, Elizabeth; Fletcher, Jerrine; Amissah, Felix et al. (2017) Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer. Oncotarget 8:31726-31744|
|Mazzio, Elizabeth A; Soliman, Karam F A (2017) HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells. Cancer Genomics Proteomics 14:17-33|
|Archibong, Edikan; Foster, Alexander; Caldwell, Keirsten et al. (2016) Synthesis, characterization, and electrospinning of novel polyaniline-peptide polymers. Appl Mater Today 4:78-82|
|Ofori, Edward; Zhu, Xue Y; Etukala, Jagan R et al. (2016) Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands. Bioorg Med Chem 24:3464-71|
|Mathis, Arlesia; Rooks, Ronica; Kruger, Daniel (2016) Improving the Neighborhood Environment for Urban Older Adults: Social Context and Self-Rated Health. Int J Environ Res Public Health 13:ijerph13010003|
|Godugu, Chandraiah; Doddapaneni, Ravi; Patel, Apurva R et al. (2016) Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma. Pharm Res 33:137-54|
|Mochona, Bereket; Jackson, Timothy; McCauley, DeCoria et al. (2016) Synthesis and Cytotoxic Evaluation of Pyrrole Hetarylazoles Containing Benzimidazole/Pyrazolone/1,3,4-Oxadiazole Motifs. J Heterocycl Chem 53:1871-1877|
|Mazzio, Elizabeth A; Li, Nan; Bauer, David et al. (2016) Natural product HTP screening for antibacterial (E.coli 0157:H7) and anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages and microglial cells; focus on sepsis. BMC Complement Altern Med 16:467|
|Etukala, Jagan R; Zhu, Xue Y; Eyunni, Suresh V K et al. (2016) Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores. Bioorg Med Chem 24:3671-9|
Showing the most recent 10 out of 204 publications